{
    "id": 29609,
    "fullName": "SLC7A11 dec exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "SLC7A11 dec exp indicates decreased expression of the Slc7a11 protein and/or mRNA. However, the mechanism causing the decreased expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 23657,
        "geneSymbol": "SLC7A11",
        "terms": [
            "SLC7A11",
            "CCBR1",
            "xCT"
        ]
    },
    "variant": "dec exp",
    "createDate": "03/28/2019",
    "updateDate": "03/28/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 16567,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, ARID1A-deficient ovarian cancer cells with decreased expression of SLC7A11 were sensitive to treatment with APR-246, demonstrating decreased cell survival in culture (PMID: 30686770).",
            "molecularProfile": {
                "id": 31682,
                "profileName": "ARID1A dec exp SLC7A11 dec exp"
            },
            "therapy": {
                "id": 1946,
                "therapyName": "APR-246",
                "synonyms": null
            },
            "indication": {
                "id": 2394,
                "name": "ovarian cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 14629,
                    "pubMedId": 30686770,
                    "title": "Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30686770"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 16568,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, ARID1A-deficient ovarian cancer cells with decreased expression of SLC7A11 were sensitive to treatment with Buthionine sulfoximine (BSO), demonstrating decreased cell survival in culture (PMID: 30686770).",
            "molecularProfile": {
                "id": 31682,
                "profileName": "ARID1A dec exp SLC7A11 dec exp"
            },
            "therapy": {
                "id": 4989,
                "therapyName": "Buthionine sulfoximine",
                "synonyms": null
            },
            "indication": {
                "id": 2394,
                "name": "ovarian cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 14629,
                    "pubMedId": 30686770,
                    "title": "Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30686770"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31681,
            "profileName": "SLC7A11 dec exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 31682,
            "profileName": "ARID1A dec exp SLC7A11 dec exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}